Business

Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth

Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth.

articleGlucose Health, Inc.December 23, 20253/company/glucose-health-inc/news/glucose-health-inc-completes-preferred-stock-conversion-at-an-85percent-premium-positioning-company-for-rapid-growth
Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth

About this update from Glucose Health, Inc.

[{"type":"text","content":"\r\n\r\n \r\n \r\n Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth\r\n \r\n \r\n\r\n\r\nGlucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth\r\n\r\n\r\n\r\n\r\n\r\nBENTONVILLE, Ark., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today announced the completion of a preferred stock conversion, in which 97% of dividend-bearing convertible preferred stock classes were converted into common stock at $0.25 per share. In addition, the remaining 3% of shares, which represent accrued dividends, earned but not paid to preferred shareholders, were cancelled through an in-kind conversion of accrued cash dividends into common stock at $0.10 per share. Following completion of the shareholder-friendly preferred stock exchange, Glucose Health, Inc. now maintains an enviable capital structure of 27,309,271 issued and outstanding common shares, and just 10,524,984 shares in the public float, which are eligible for trading in the open market. The conversion of preferred shares into common shares should also help to create additional liquidity for the shares of GLUC, which trade on the Over-the-Counter marketplace. Currently, Glucose Health, Inc. has a total of 2,200,000 issued and outstanding warrants convertible into 2,200,000 common shares held by the Company’s management team. If exercised, the warrants would provide future working capital for the company. On a fully-diluted basis Glucose Health’s total common shares equals 29,509,271. Under the terms of the preferred stock agreement, ratified by the preferred shareholders, a total of 6,674,292 preferred shares were converted into 6,674,292 common shares at cost basis of $0.25 per common share. This block of 97% of preferred shares, converted by shareholders, represents an 85% premium over the current market price of GLUC shares. At the same time, the 188,014 preferred shares, representing the accumulated preferred dividends were converted into 188,014 common shares at cost basis of $0.10 per share. The agreement with preferred shareholders eliminates all dividend-bearing preferred share classes, extinguishes the related balance-sheet liabi...

More updates from Glucose Health, Inc.